fullerene c60 has been researched along with Carcinoma, Ductal, Breast in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baltić, VV; Bogdanović, G; Canadanović-Brunet, J; Dordević, A; Kojić, V; Vojinović-Miloradov, M | 1 |
1 other study(ies) available for fullerene c60 and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Female; Fullerenes; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Spin Trapping | 2004 |